Cancer-Stroma Targeting Therapy by Cytotoxic Immunoconjugate Bound to the Collagen 4 Network in the Tumor Tissue-Reference-Cited by-同舟云学术

Cancer-Stroma Targeting Therapy by Cytotoxic Immunoconjugate Bound to the Collagen 4 Network in the Tumor Tissue

Published:2011-08-04 Issue:9 Volume:22 Page:1776-1783
ISSN:1043-1802
Container-title:Bioconjugate Chemistry
language:en
Short-container-title:Bioconjugate Chem.

Author:

Yasunaga Masahiro¹,Manabe Shino²,Tarin David³,Matsumura Yasuhiro¹

Affiliation:

1. Investigative Treatment Division, Research Center for Innovative Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan

2. Synthetic Cellular Chemistry Laboratory, RIKEN Advanced Science Institute, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan

3. Department of Pathology and Moores/UCSD Comprehensive Cancer Center, University of California, San Diego, 3855 Health Sciences Drive MC 0803, La Jolla, California, 92093-0803, United States

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Pharmaceutical Science,Pharmacology,Biomedical Engineering,Bioengineering,Biotechnology

Link

https://pubs.acs.org/doi/pdf/10.1021/bc200158j

Reference35 articles.

1. Nanocarriers as an emerging platform for cancer therapy

2. Nanoparticle therapeutics: an emerging treatment modality for cancer

3. The dawning era of polymer therapeutics

4. Poly (amino acid) micelle nanocarriers in preclinical and clinical studies

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibody-drug conjugates for hepato-pancreato-biliary malignancies: “Magic bullets” to the rescue?;Cancer Treatment Reviews;2024-09

2. Expanding horizons in cancer therapy by immunoconjugates targeting tumor microenvironments;Critical Reviews in Oncology/Hematology;2024-09

3. Single-Domain Antibodies as Antibody–Drug Conjugates: From Promise to Practice—A Systematic Review;Cancers;2024-07-27

4. Contemporary Approaches to Immunotherapy of Solid Tumors;Cancers;2024-06-19

5. Modulating extracellular matrix stiffness: a strategic approach to boost cancer immunotherapy;Cell Death & Disease;2024-05-01